Resonance HealthASX:RHT +4.55% Pretax Margin % is 11.35% as of Dec. 2025. The stock has 6 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Resonance Health ranks worse than 58.08% on this metric.
The historical rank and industry rank for Resonance Health's Pretax Margin % or its related term are showing as below:
ASX:RHT'
s Pretax Margin % Range Over the Past 10 Years
Min: -40.54 Med: -19.43 Max: 25.99
Current: 1.56
ASX:RHT's Pretax Margin % is ranked worse than 58.08% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 3.97
vs ASX:RHT: 1.56
Resonance Health (ASX:RHT) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Resonance Health Pretax Margin % Related Terms
Resonance Health Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Resonance Health's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:RHT vs VEEV, BTSG, TEM: Pretax Margin % Comparison
For the Health Information Services subindustry, Resonance Health's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Resonance Health Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Resonance Health's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Resonance Health's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Resonance Health (ASX:RHT) has a Pretax Margin % of 11.35% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Resonance Health and its competitors. According to the industry distribution chart, Resonance Health ranks #388 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 58.1%.
Is Resonance Health's Pretax Margin % too high?
Resonance Health's current Pretax Margin % is 11.35%. The Healthcare Providers & Services industry median Pretax Margin % is 3.97. Resonance Health's value of 11.35% is 185.9% above this industry median. Based on the distribution chart, Resonance Health ranks #388 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Resonance Health's Pretax Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Resonance Health ranks #388 out of 668 companies for Pretax Margin %. This places Resonance Health in the lower half of its industry. The industry median Pretax Margin % is 3.97. Resonance Health's value of 11.35% is 185.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 3.97, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Resonance Health's current Pretax Margin % of 11.35% is 185.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Resonance Health and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 3.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Resonance Health's current Pretax Margin % is 11.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Resonance Health stock overvalued right now?
Based on GuruFocus' analysis, Resonance Health (ASX:RHT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.12, compared to a current price of A$0.05 — trading 61.7% below its estimated fair value. The current Pretax Margin % is 11.35% and 185.9% above the Healthcare Providers & Services industry median of 3.97. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Resonance Health (ASX:RHT), the current Pretax Margin % is 11.35% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Resonance Health Ltd is engaged in the development and commercialisation of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. The Group's core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. The Company also has several AI-assisted SaMDs including FerriSmart, HepaFatSmart, and LiverSmart. Its business segments are; SaMD1 which derives key revenue, Corporate, TrialsWest, and Resonance Clinica. Geographically, it generates maximum revenue from the Asia Pacific region and the rest from North America, and Europe, Middle East and Africa (EMEA) regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:RHT has been successfully added to your 